HIGHLIGHTS
- who: Bao-Hui Cheng and collaborators from the Universitu00e9 Paris Citu00e9, FranceShenzhen University have published the Article: Editorial: Mechanisms and advances in respiratory allergic diseases, in the Journal: (JOURNAL) of 28/03/2023
- future: As available monoclonal antibody treatments have shown little benefit among patients with T2-low asthma research continues in this area with several antibodies in development. based on dinitrophenol (DNP)-human serum albumin (HSA) stimulation from IgE-sensitized mast cells. These data indicate that dysbiosis-related immunemodulation with long-term effects on asthma development occurs to a lesser extent prenatally and will . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.